Experimental evidence shows that CD73 expression is significantly upregulated under in vitro hypoxic conditions, both at the mRNA level (NT5E) and on CLL cell surface [3], in line with previous observation of a direct transcriptional control of NT5E by HIF1α [111]. This evidence concerns the gene NT5E and B-cell chronic lymphocytic leukemia.